LabCompass

Emma Leishman

Medicine · Indiana University

Publications

72

Citations

2,357

Est. group size

Recurring co-author estimate

Active years

20

Publishing since 2006

Research summary
AI-generated

Emma Leishman conducts biomedical research spanning two main directions: the study of blood clotting (coagulation) and thrombotic risk, including how factors like pregnancy and hormone therapy affect the tendency to form clots, and pharmacology topics such as cannabinoids, neuropharmacology, and drug analysis. Recent work also includes developing a chemical method for safely disposing of controlled medications. The research combines laboratory analysis of blood markers with clinical and drug-safety applications.

Coagulation and thrombotic riskPregnancy and hormone-related blood changesCannabinoid and neuropharmacology researchForensic toxicology and drug analysisSafe medication disposal

Publication activity has declined over the last decade, dropping from around a dozen papers per year in 2017 to only one or two in recent years (averaging about 1.4 per year over the last five years).

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
2017: 12 publications12172018: 7 publications182019: 9 publications192020: 4 publications202021: 3 publications212022: 1 publication222023: 3 publications232024: 1 publication242025: 2 publications2526
Publishes in
  • Investigative Ophthalmology & Visual Science×4
  • bioRxiv (Cold Spring Harbor Laboratory)×4
  • Thrombosis Research×3
  • Cannabis and Cannabinoid Research×2
  • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile